Background Summary - nc
... health divisions in all 50 states) to build and strengthen epidemiology, laboratory and health information systems capacity. The goal of the 3 year project, called Healthcare Infection Control and Response, is to bolster infection control practice and competency throughout the NC healthcare delivery ...
... health divisions in all 50 states) to build and strengthen epidemiology, laboratory and health information systems capacity. The goal of the 3 year project, called Healthcare Infection Control and Response, is to bolster infection control practice and competency throughout the NC healthcare delivery ...
Comparison of respiratory virus infection between human
... cells and Hep2G cells, respectively. Twenty µl of supernatant was collected and 10-fold serial dilutions of the supernatant were prepared with DMEM containing 1% FCS. All titrations were performed by infecting confluent Hela/Hep2G cell monolayers in 96 well plate with serially diluted supernatant (1 ...
... cells and Hep2G cells, respectively. Twenty µl of supernatant was collected and 10-fold serial dilutions of the supernatant were prepared with DMEM containing 1% FCS. All titrations were performed by infecting confluent Hela/Hep2G cell monolayers in 96 well plate with serially diluted supernatant (1 ...
BLOODBORNE PATHOGENS TRAINING
... Performed under the supervision of someone smart Administered according to the standard recommendations for medical practice current at the time of testing – a) The department shall not make TB testing mandatory. – b) The department shall ensure that members who decline to accept TB testing si ...
... Performed under the supervision of someone smart Administered according to the standard recommendations for medical practice current at the time of testing – a) The department shall not make TB testing mandatory. – b) The department shall ensure that members who decline to accept TB testing si ...
Vaccine Preventable Diseases and healthcare workers
... • Immunity following vaccination or natural infection generally lasts for months to many years depending on the nature of the vaccine and host factors1. • Some vaccine courses require more than one dose. ...
... • Immunity following vaccination or natural infection generally lasts for months to many years depending on the nature of the vaccine and host factors1. • Some vaccine courses require more than one dose. ...
Interpret a (+)HBeAg, anti-HBcAg, and/or anti-HCV test
... American College of Rheumatology . 1990 Criteria For the Classification of Polyarteritis Nodosa . Retrieved Aug 25, 2009 from http://www.rheumatology.org/publications/classification/polyart.asp . ...
... American College of Rheumatology . 1990 Criteria For the Classification of Polyarteritis Nodosa . Retrieved Aug 25, 2009 from http://www.rheumatology.org/publications/classification/polyart.asp . ...
medication ex.) antibiotics (to kill the bacteria)
... uncontrolled cell growth in tissues of the lung The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss. ...
... uncontrolled cell growth in tissues of the lung The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss. ...
Diseases from the Past
... strain is made more difficult by the fact that the flu virus is capable of very rapid mutations ...
... strain is made more difficult by the fact that the flu virus is capable of very rapid mutations ...
Passive and active immunity
... ability of lymphocytes to develop memory for a pathogen's antigens underlie vaccination. Active immunization is known as vaccination. A wide range of antigen preparations are in use as vaccines, from whole organisms to simple peptides and sugars. Living and non-living vaccines have important differe ...
... ability of lymphocytes to develop memory for a pathogen's antigens underlie vaccination. Active immunization is known as vaccination. A wide range of antigen preparations are in use as vaccines, from whole organisms to simple peptides and sugars. Living and non-living vaccines have important differe ...
Human to Human Transmission of Infectious Diseases
... Can affect any organ system Dangerous when it is pulmonary - you cough up the bugs and spread them ...
... Can affect any organ system Dangerous when it is pulmonary - you cough up the bugs and spread them ...
II. Classification of Microorganisms
... • Nucleocapsid consists of DNA surrounded by hepatitis B core antigen (HBcAg) • The core is surrounded by a lipoprotein envelope containing the hepatitis B surface antigen (HBsAg) • The virus has also been called the Dane particle • Large amounts of excess HBsAg are found in the serum & may be detec ...
... • Nucleocapsid consists of DNA surrounded by hepatitis B core antigen (HBcAg) • The core is surrounded by a lipoprotein envelope containing the hepatitis B surface antigen (HBsAg) • The virus has also been called the Dane particle • Large amounts of excess HBsAg are found in the serum & may be detec ...
Chronic disease management of HIV
... ● Overview of HIV care ● Chronic disease management ● Conclusion ...
... ● Overview of HIV care ● Chronic disease management ● Conclusion ...
The Present - Viral Hepatitis Prevention Board
... • The hepatitis B prevention measures together with those directed to HIV have also caused a reduction of new HCV infections. • The health-care and social burden of chronic disease associated both with HBV and especially with HCV still remains relevant. This burden has not so far been positively inf ...
... • The hepatitis B prevention measures together with those directed to HIV have also caused a reduction of new HCV infections. • The health-care and social burden of chronic disease associated both with HBV and especially with HCV still remains relevant. This burden has not so far been positively inf ...
outline infection control
... Microorganisms To be able to live………… must survive the ____________ of Infection Are everywhere Cycle of Transmission Infectious agent/pathogen: the organism causing the infection Reservoir-The host: the infected person or animal “carrying” the pathogen…..Where it all begins Portal of exit-how it le ...
... Microorganisms To be able to live………… must survive the ____________ of Infection Are everywhere Cycle of Transmission Infectious agent/pathogen: the organism causing the infection Reservoir-The host: the infected person or animal “carrying” the pathogen…..Where it all begins Portal of exit-how it le ...
Vaccines for Dogs - Alta View Veterinary Clinic
... tissues in the dog’s body producing diarrhea, fever, nasal and ocular discharge, respiratory disease, appetite loss and neurologic signs such as muscular spasms and paralysis. PARVOVIRUS: Parvovirus is a viral disease of dogs that causes severe diarrhea and vomiting. Depression and loss of appetite ...
... tissues in the dog’s body producing diarrhea, fever, nasal and ocular discharge, respiratory disease, appetite loss and neurologic signs such as muscular spasms and paralysis. PARVOVIRUS: Parvovirus is a viral disease of dogs that causes severe diarrhea and vomiting. Depression and loss of appetite ...
Select the most appropriate answer for each question (1
... (C) Have their own metabolism (D) May contain enzymes for replication (E) Are intracellular parasites 2. Which of the following is not an enveloped virus? (A) Variola virus (B) Adenovirus (C) Epstein-Barr virus (D) Varicella-zoster virus (E) Hepatitis B virus 3. Which of the following is a DNA tumor ...
... (C) Have their own metabolism (D) May contain enzymes for replication (E) Are intracellular parasites 2. Which of the following is not an enveloped virus? (A) Variola virus (B) Adenovirus (C) Epstein-Barr virus (D) Varicella-zoster virus (E) Hepatitis B virus 3. Which of the following is a DNA tumor ...
Immune System and Virus Review Sheet
... Be able to discuss the difference between Active and Passive Immunity Be able to give examples of how you get Active and Passive Immunity Know how these early Scientists helped us learn more about Infectious diseases- Louis Pasteur, Robert Koch, and Joseph Lister Know the 4 types of pathogens that c ...
... Be able to discuss the difference between Active and Passive Immunity Be able to give examples of how you get Active and Passive Immunity Know how these early Scientists helped us learn more about Infectious diseases- Louis Pasteur, Robert Koch, and Joseph Lister Know the 4 types of pathogens that c ...
Communicable disease 2017
... • pregnant woman is infected, she can pass Zika virus to her fetus during pregnancy or around the time of birth. • Zika virus can also be passed through sex from an infected person to his or her partners, • Another probable route of transmission for Zika virus is through blood transfusions. ...
... • pregnant woman is infected, she can pass Zika virus to her fetus during pregnancy or around the time of birth. • Zika virus can also be passed through sex from an infected person to his or her partners, • Another probable route of transmission for Zika virus is through blood transfusions. ...
Set 5 Transmission
... (not inhaled) • “blood-borne”: Hepatitis B, HIV-1 and HIV-2 • “sexually-transmitted” or “STDs” or “urogenital”: Hepatitis B, HIV-1 and HIV-2, syphilis, gonorrhea, chlamydia • Herpes viruses like Epstein-Barr Virus can be transmitted through saliva (“mono” or “kissing disease”) ...
... (not inhaled) • “blood-borne”: Hepatitis B, HIV-1 and HIV-2 • “sexually-transmitted” or “STDs” or “urogenital”: Hepatitis B, HIV-1 and HIV-2, syphilis, gonorrhea, chlamydia • Herpes viruses like Epstein-Barr Virus can be transmitted through saliva (“mono” or “kissing disease”) ...
Final Report: SIBURIAN - International Society for Infectious Diseases
... 9. Utama A, Octavia TI, Dhenni R, Miskad UA, Yusuf I, Tai S. Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J 2009; 6: 128. 10. Lusida MI, Nugrahaputra VE, Soetjipto, et al. Novel subgenotypes of hepatitis B virus genotypes C and D ...
... 9. Utama A, Octavia TI, Dhenni R, Miskad UA, Yusuf I, Tai S. Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virol J 2009; 6: 128. 10. Lusida MI, Nugrahaputra VE, Soetjipto, et al. Novel subgenotypes of hepatitis B virus genotypes C and D ...
18.2 Viral Structure and Reproduction
... 18.2 Viral Structure and Reproduction • A lysogenic infection does no immediate harm. The prophage may leave the host’s DNA and enter the lytic cycle. The viral DNA is called a prophage when it combines with the host cell’s DNA. ...
... 18.2 Viral Structure and Reproduction • A lysogenic infection does no immediate harm. The prophage may leave the host’s DNA and enter the lytic cycle. The viral DNA is called a prophage when it combines with the host cell’s DNA. ...
HIV Replication 3D Medical Animation
... It has two catalytic domains: The Ribonuclease-H active site And the polymerase active site Here single stranded viral RNA is transcribed into an RNA-DNA double helix. Ribonuclease- H breaks down the RNA. The polymerase then completes the remaining DNA-strand to form a DNA -double helix. Now Integra ...
... It has two catalytic domains: The Ribonuclease-H active site And the polymerase active site Here single stranded viral RNA is transcribed into an RNA-DNA double helix. Ribonuclease- H breaks down the RNA. The polymerase then completes the remaining DNA-strand to form a DNA -double helix. Now Integra ...
vaccine - Fatchiyah
... How does vaccination work? Expose the patient to an Antigen A live or inactivated substance derived from a pathogen (e.g bacteria or virus)capable of producing an immune response ...
... How does vaccination work? Expose the patient to an Antigen A live or inactivated substance derived from a pathogen (e.g bacteria or virus)capable of producing an immune response ...
Hepatitis B
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, feeling tired, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications results in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. Diagnosis is typically by testing the blood for parts of the virus and for antibodies against the virus. It is one of five known hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease antiviral medication such as tenofovir or interferon maybe useful, however these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%. It was originally known as serum hepatitis. Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.